PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-32

  1. 41 Posts.
    lightbulb Created with Sketch. 10
    To me it continues to read as the FDA is stalling. One of 6? From 1 of the 26 studies?

    uhhh…

    Crazy they just shoved vaccines in arms at this rate. Good grief.

    Phase3 will start at the Beginning of Q4.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.